Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro

Despite the successful development of vaccines and neutralizing antibodies to limit the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerging variants prolong the pandemic and emphasize the persistent need to develop effective antiviral treatment regimens. Recombinant anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zekri, Latifa, Ruetalo, Natalia, Christie, Mary, Walker, Carolin, Manz, Timo, Rammensee, Hans-Georg, Salih, Helmut R., Schindler, Michael, Jung, Gundram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030959/
https://www.ncbi.nlm.nih.gov/pubmed/36969164
http://dx.doi.org/10.3389/fimmu.2023.1112505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030959/
https://www.ncbi.nlm.nih.gov/pubmed/36969164
http://dx.doi.org/10.3389/fimmu.2023.1112505

Ejemplares similares